Skip to main content
Erschienen in: Forensic Toxicology 2/2017

01.06.2017 | Original Article

Earwax: an innovative tool for assessment of tobacco use or exposure. A pilot study in young adults

verfasst von: Engy Shokry, Anselmo Elcana de Oliveira, Melissa Ameloti Gomes Avelino, Mariana Moreira de Deus, Naiara Zedes Pereira, Nelson Roberto Antoniosi Filho

Erschienen in: Forensic Toxicology | Ausgabe 2/2017

Einloggen, um Zugang zu erhalten

Abstract

The present work represents a novel approach using earwax (cerumen) for the evaluation of the smoking status with regards to tobacco use/exposure. The method utilizes the difference in the concentration profiles of nicotine and its related compounds in earwax to discriminate among non-, passive, and active smokers. Earwax samples were collected from three study groups (non-, passive, and active smokers) and subjected to analysis by headspace gas chromatography–mass spectrometry. The nicotine levels in earwax were much lower than cotinine levels, even for active smokers; however, it was reported that the nicotine levels in scalp hair were much higher than the cotinine levels. Therefore, it is obviously correct that earwax is protected from external contamination to a larger extent than expected. The concentration profiles of nicotine and its related compounds (o-nicotine, cotinine, and anabasine) in the analyzed earwax samples were treated by data mining techniques. It was possible to discriminate the studied groups using the evolutionary tree (evtree) algorithm and support vector machine discriminant analysis as the statistical models with the best discrimination accuracies of 96.7 and 95.0%, respectively. The analytical method applied requires no sample pretreatment which makes it easy, fast, and a low-cost alternative method to those employing other biological matrices, such as blood, urine, and hair. The earwax, which is considered a neglected body secretion, is a useful tool to determine the exposure to tobacco smoke noninvasively and without the influence of external contamination.
Literatur
1.
Zurück zum Zitat Hu Q, Hou H (2015) Tobacco smoke exposure biomarkers. CRC Press, Boca RatonCrossRef Hu Q, Hou H (2015) Tobacco smoke exposure biomarkers. CRC Press, Boca RatonCrossRef
2.
Zurück zum Zitat Haufroid V, Lison D (1998) Urinary cotinine as a tobacco smoke exposure index: a minireview. Int Arch Occup Environ Health 71:162–168CrossRefPubMed Haufroid V, Lison D (1998) Urinary cotinine as a tobacco smoke exposure index: a minireview. Int Arch Occup Environ Health 71:162–168CrossRefPubMed
3.
Zurück zum Zitat Martinet Y, Wirth N (2013) Respiratory medicine. European Respiratory Society, Sheffield Martinet Y, Wirth N (2013) Respiratory medicine. European Respiratory Society, Sheffield
4.
Zurück zum Zitat Doctor PB, Gokani VN, Kulkami PK, Parikh JR, Saiyed HN (2004) Determination of nicotine and cotinine in tobacco harvester’s urine by solid-phase extraction and liquid chromatography. J Chromatogr B 802:323–328CrossRef Doctor PB, Gokani VN, Kulkami PK, Parikh JR, Saiyed HN (2004) Determination of nicotine and cotinine in tobacco harvester’s urine by solid-phase extraction and liquid chromatography. J Chromatogr B 802:323–328CrossRef
5.
6.
Zurück zum Zitat Kim I, Huestis MA (2006) A validated method for the determination of nicotine, cotinine, trans-3′-hydroxycotinine, and norcotinine in human plasma using solid-phase extraction and liquid chromatography-atmospheric pressure chemical ionization-mass spectrometry. J Mass Spectrom 41:815–821CrossRefPubMed Kim I, Huestis MA (2006) A validated method for the determination of nicotine, cotinine, trans-3′-hydroxycotinine, and norcotinine in human plasma using solid-phase extraction and liquid chromatography-atmospheric pressure chemical ionization-mass spectrometry. J Mass Spectrom 41:815–821CrossRefPubMed
7.
8.
Zurück zum Zitat Schwartz RS, Benowitz NL (2010) Nicotine addiction. N Engl J Med 362:2295–2303CrossRef Schwartz RS, Benowitz NL (2010) Nicotine addiction. N Engl J Med 362:2295–2303CrossRef
9.
Zurück zum Zitat Skarping G, Willers S, Dalene M (1988) Determination of cotinine in urine using glass capillary gas chromatography and selective detection, with special reference to the biological monitoring of passive smoking. J Chromatogr 454:293–301CrossRefPubMed Skarping G, Willers S, Dalene M (1988) Determination of cotinine in urine using glass capillary gas chromatography and selective detection, with special reference to the biological monitoring of passive smoking. J Chromatogr 454:293–301CrossRefPubMed
10.
Zurück zum Zitat Haley NJ, Sepkovic DW, Hoffman D (1989) Elimination of cotinine from body fluids: disposition in smokers and non-smokers. Am J Public Health 79:1046–1048CrossRefPubMedPubMedCentral Haley NJ, Sepkovic DW, Hoffman D (1989) Elimination of cotinine from body fluids: disposition in smokers and non-smokers. Am J Public Health 79:1046–1048CrossRefPubMedPubMedCentral
11.
Zurück zum Zitat Willers S, Skarping G, Dalene M, Skerfving S (1995) Urinary cotinine in children and adults during and after semiexperimental exposure to environmental tobacco smoke. Arch Environ Health 50:130–138CrossRefPubMed Willers S, Skarping G, Dalene M, Skerfving S (1995) Urinary cotinine in children and adults during and after semiexperimental exposure to environmental tobacco smoke. Arch Environ Health 50:130–138CrossRefPubMed
12.
Zurück zum Zitat Jacob P, Shulgin AT, Yu L, Benowitz NL (1992) Determination of the nicotine metabolite trans-3 hydroxycotinine in urine of smokers using gas chromatography with nitrogen-selective detection or selected ion monitoring. J Chromatogr B 583:145–154CrossRef Jacob P, Shulgin AT, Yu L, Benowitz NL (1992) Determination of the nicotine metabolite trans-3 hydroxycotinine in urine of smokers using gas chromatography with nitrogen-selective detection or selected ion monitoring. J Chromatogr B 583:145–154CrossRef
13.
Zurück zum Zitat Jacob P III, Yu L, Liang G, Shulgin AT, Benowitz NL (1993) Gas chromatographic-mass spectrometric method for determination of anabasine, anatabine and other tobacco alkaloids in urine of smokers and smokeless tobacco users. J Chromatogr 619:49–61CrossRefPubMed Jacob P III, Yu L, Liang G, Shulgin AT, Benowitz NL (1993) Gas chromatographic-mass spectrometric method for determination of anabasine, anatabine and other tobacco alkaloids in urine of smokers and smokeless tobacco users. J Chromatogr 619:49–61CrossRefPubMed
14.
Zurück zum Zitat Jacob P III, Yu L, Shulgin AT, Benowitz NL (1999) Minor tobacco alkaloids as biomarkers for tobacco use: comparison of users of cigarettes, smokeless tobacco, cigars, and pipes. Am J Public Health 89:731–736CrossRefPubMedPubMedCentral Jacob P III, Yu L, Shulgin AT, Benowitz NL (1999) Minor tobacco alkaloids as biomarkers for tobacco use: comparison of users of cigarettes, smokeless tobacco, cigars, and pipes. Am J Public Health 89:731–736CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat Florescu A, Ferrence R, Einarson T, Selby P, Soldin O, Koren G (2009) Methods for quantification of exposure to cigarette smoking and environmental tobacco smoke: focus on developmental toxicology. Ther Drug Monit 31:14–30CrossRefPubMedPubMedCentral Florescu A, Ferrence R, Einarson T, Selby P, Soldin O, Koren G (2009) Methods for quantification of exposure to cigarette smoking and environmental tobacco smoke: focus on developmental toxicology. Ther Drug Monit 31:14–30CrossRefPubMedPubMedCentral
16.
Zurück zum Zitat Boumba VA, Ziavrou KS, Vougiouklakis T (2006) Hair as a biological indicator of drug use, drug abuse or chronic exposure to environmental toxicants. Int J Toxicol 25:143–163CrossRefPubMed Boumba VA, Ziavrou KS, Vougiouklakis T (2006) Hair as a biological indicator of drug use, drug abuse or chronic exposure to environmental toxicants. Int J Toxicol 25:143–163CrossRefPubMed
17.
Zurück zum Zitat Prokop-Prigge KA, Thaler E, Wysocki CJ, Preti G (2014) Identification of volatile organic compounds in human cerumen. J Chromatogr B 953–954:48–52CrossRef Prokop-Prigge KA, Thaler E, Wysocki CJ, Preti G (2014) Identification of volatile organic compounds in human cerumen. J Chromatogr B 953–954:48–52CrossRef
19.
20.
Zurück zum Zitat Guest JF, Greener MJ, Robinson AC, Smith AF (2004) Impacted cerumen: composition, production, epidemiology and management. QJM 97:477–488CrossRefPubMed Guest JF, Greener MJ, Robinson AC, Smith AF (2004) Impacted cerumen: composition, production, epidemiology and management. QJM 97:477–488CrossRefPubMed
21.
Zurück zum Zitat De Giovanni N, Fucci N (2013) The current status of sweat testing for drugs of abuse: a review. Curr Med Chem 20:545–561PubMed De Giovanni N, Fucci N (2013) The current status of sweat testing for drugs of abuse: a review. Curr Med Chem 20:545–561PubMed
22.
Zurück zum Zitat Stepanov I, Feuer R, Jensen J, Hatsukami D, Hecht SS (2006) Mass spectrometric quantitation of nicotine, cotinine, and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol in human toenails. Cancer Epidemiol Biomark Prev 15:2378–2383CrossRef Stepanov I, Feuer R, Jensen J, Hatsukami D, Hecht SS (2006) Mass spectrometric quantitation of nicotine, cotinine, and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol in human toenails. Cancer Epidemiol Biomark Prev 15:2378–2383CrossRef
23.
Zurück zum Zitat Rebagliato M, Bol F, Florey CV, Jarvis MJ, Pérez-Hoyos S, Hern I, Avi MJ (1998) Variations in cotinine levels in smokers during and after pregnancy. Am J Obstet Gynecol 178:568–571CrossRefPubMed Rebagliato M, Bol F, Florey CV, Jarvis MJ, Pérez-Hoyos S, Hern I, Avi MJ (1998) Variations in cotinine levels in smokers during and after pregnancy. Am J Obstet Gynecol 178:568–571CrossRefPubMed
24.
Zurück zum Zitat Hu Q, Hou H (2015) Guidance for industry bioanalytical method validation by the food and drug administration. Tobacco smoke exposure biomarkers. CRC Press, Boca Raton, pp 247–264 Hu Q, Hou H (2015) Guidance for industry bioanalytical method validation by the food and drug administration. Tobacco smoke exposure biomarkers. CRC Press, Boca Raton, pp 247–264
26.
Zurück zum Zitat Christmann A, Fischer P, Joachims T (2002) Classification based on the support vector machine, regression depth, and discriminant analysis. In: Härdle W, Rönz B (eds) Compstat. Proceedings in computational statistics. Springer, Heidelberg, pp 225–230 Christmann A, Fischer P, Joachims T (2002) Classification based on the support vector machine, regression depth, and discriminant analysis. In: Härdle W, Rönz B (eds) Compstat. Proceedings in computational statistics. Springer, Heidelberg, pp 225–230
27.
Zurück zum Zitat Grubinger T, Zeileis A, Pfeiffer KP (2014) evtree: evolutionary learning of globally optimal classification and regression trees in R. J Stat Softw. doi:10.18637/jss.v061.i01 Grubinger T, Zeileis A, Pfeiffer KP (2014) evtree: evolutionary learning of globally optimal classification and regression trees in R. J Stat Softw. doi:10.​18637/​jss.​v061.​i01
28.
Zurück zum Zitat Scholkopf B, Burges CJC, Smola AJ (eds) (1999) Advances in kernel methods. Support vector learning. MIT Press, Cambridge, pp 1–376 (ISBN 0–262–19416–3) Scholkopf B, Burges CJC, Smola AJ (eds) (1999) Advances in kernel methods. Support vector learning. MIT Press, Cambridge, pp 1–376 (ISBN 0–262–19416–3)
29.
Zurück zum Zitat Ben-Hur A, Weston J (2010) A user’s guide to support vector machines. Methods Mol Biol 609:223–239CrossRefPubMed Ben-Hur A, Weston J (2010) A user’s guide to support vector machines. Methods Mol Biol 609:223–239CrossRefPubMed
30.
Zurück zum Zitat Meier TB, Desphande AS, Vergun S, Nair VA, Song J, Biswal BB (2012) Support vector machine classification and characterization of age-related reorganization of functional brain networks. Neuroimage 60:601–613CrossRefPubMed Meier TB, Desphande AS, Vergun S, Nair VA, Song J, Biswal BB (2012) Support vector machine classification and characterization of age-related reorganization of functional brain networks. Neuroimage 60:601–613CrossRefPubMed
31.
Zurück zum Zitat Fuji J, Higashi A, Matsuda I, Nakano M (2001) Measurement of concentrations of nicotine and cotinine in maternal and neonatal hair. Jpn J Clin Pharmacol Ther 32:119–125CrossRef Fuji J, Higashi A, Matsuda I, Nakano M (2001) Measurement of concentrations of nicotine and cotinine in maternal and neonatal hair. Jpn J Clin Pharmacol Ther 32:119–125CrossRef
32.
Zurück zum Zitat Tsuji M, Mori Y, Kanda H, Ito T, Hidaka T, Kakamu T, Kumagai T, Hayakawa T, Osaki Y, Fukushima T (2013) Development of simple HPLC/UV with a column–switching method for the determination of nicotine and cotinine in hair samples. Health 5:687–694. doi:10.4236/health.2013.54091 CrossRef Tsuji M, Mori Y, Kanda H, Ito T, Hidaka T, Kakamu T, Kumagai T, Hayakawa T, Osaki Y, Fukushima T (2013) Development of simple HPLC/UV with a column–switching method for the determination of nicotine and cotinine in hair samples. Health 5:687–694. doi:10.​4236/​health.​2013.​54091 CrossRef
Metadaten
Titel
Earwax: an innovative tool for assessment of tobacco use or exposure. A pilot study in young adults
verfasst von
Engy Shokry
Anselmo Elcana de Oliveira
Melissa Ameloti Gomes Avelino
Mariana Moreira de Deus
Naiara Zedes Pereira
Nelson Roberto Antoniosi Filho
Publikationsdatum
01.06.2017
Verlag
Springer Japan
Erschienen in
Forensic Toxicology / Ausgabe 2/2017
Print ISSN: 1860-8965
Elektronische ISSN: 1860-8973
DOI
https://doi.org/10.1007/s11419-017-0370-0

Weitere Artikel der Ausgabe 2/2017

Forensic Toxicology 2/2017 Zur Ausgabe

Neu im Fachgebiet Rechtsmedizin

Molekularpathologische Untersuchungen im Wandel der Zeit

Open Access Biomarker Leitthema

Um auch an kleinen Gewebeproben zuverlässige und reproduzierbare Ergebnisse zu gewährleisten ist eine strenge Qualitätskontrolle in jedem Schritt des Arbeitsablaufs erforderlich. Eine nicht ordnungsgemäße Prüfung oder Behandlung des …

Vergleichende Pathologie in der onkologischen Forschung

Pathologie Leitthema

Die vergleichende experimentelle Pathologie („comparative experimental pathology“) ist ein Fachbereich an der Schnittstelle von Human- und Veterinärmedizin. Sie widmet sich der vergleichenden Erforschung von Gemeinsamkeiten und Unterschieden von …

Gastrointestinale Stromatumoren

Open Access GIST CME-Artikel

Gastrointestinale Stromatumoren (GIST) stellen seit über 20 Jahren ein Paradigma für die zielgerichtete Therapie mit Tyrosinkinaseinhibitoren dar. Eine elementare Voraussetzung für eine mögliche neoadjuvante oder adjuvante Behandlung bei …

Personalisierte Medizin in der Onkologie

Aufgrund des erheblichen technologischen Fortschritts in der molekularen und genetischen Diagnostik sowie zunehmender Erkenntnisse über die molekulare Pathogenese von Krankheiten hat in den letzten zwei Jahrzehnten ein grundlegender …